EPIDEMIOLOGY OF THE MOST COMMON MENTAL DISORDERS IN PATIENTS WITH DIABETES MELLITUS
- Authors: Starostina E.G.1,2, Moshnyaga E.N.1,2, Volodina M.N.1,2, Malakhova T.S.3,4
-
Affiliations:
- Moscow Regional Research and Clinical Institute (MONIKI)
- 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
- Regional Hospital No.3
- 1 Frunze ul., Shchelkovo, Shchelkovskiy r-n, Moscow Region, 141100, Russian Federation
- Issue: No 32 (2014)
- Pages: 17-23
- Section: ARTICLES
- URL: https://almclinmed.ru/jour/article/view/124
- DOI: https://doi.org/10.18786/2072-0505-2014-32-17-23
- ID: 124
Cite item
Full Text
Abstract
Background: Non-psychotic mental disorders including non-severe depressive, anxiety and organic disorders can have an impact on the course and prognosis of the underlying disease in patients with diabetes mellitus (DM). Therefore, assessment of their epidemiologic aspects is extremely important. Aim: Investigation of the types and prevalence of the major mental disorders among both type 1 DM (T1DM) and type 2 DM (T2DM) in-patients, determination of possible etiology of the organic involvement of the brain in T1DM patients as well as of the rate of diagnostics and management of mental disorders in DM patients in routine medical practice. Materials and methods: Part 1 was a cross-sectional study in 228 consecutive DM patients aged from 18 to 75 years, aimed at detection of current mental disorders. Part 2 was a cross-sectional study in 72 consecutive T1DM patients with in-depth assessment of signs of organic brain involvement. All patients underwent cognitive function tests. Mental disorders were diagnosed by a psychiatrist according to ICD-10 diagnostic criteria. Results: Mental disorders were found in 80.3% of patients, being significantly more prevalent in patients with T2DM (87.9%) than in T1DM patients (57.4%, р<0.0001). Anxiety disorders as a whole were diagnosed as frequently as depressive ones (39.5% and 40.0%, respectively), being the most prevalent both in T1DM (35%) and T2DM (60%). Within the class of anxiety disorders, diabetes-specific phobias of injections and hypoglycemia were noted 8-fold more often (р<0.01) in T1DM than in T2DM patients. Generalized (22.4 versus 9.3%) and organic (18 versus 0%) anxiety disorders as well as unipolar depressive episodes and dysthymia (40.2 versus 25.9%, р<0.05) occurred considerably more often in T2DM than in T1DM patients. In total, signs of organic brain involvement were found in 37% of T1DM patients. Possible etiologic factors of organic brain disorders were as follows: craniocerebral injury including concussion of the brain, severe hypoglycemia, and diabetic ketoacidosis – in 40.7% of patients each; alcohol abuse – 30.7%; arterial hypertension – 22.2%; ante- and intranatal factors – 11.1%; neuroinfections/intoxications and occupational neurotropic factors – in 7.4% each; electric trauma, general malnutrition, stroke, and brain tumor – in 3.7% each. None of the listed potential causes could be found only in one patient with organic brain involvement (3.7%). In T1DM patients, organic brain involvement was nonspecific, and there was no evidence of its association with the level of glycated hemoglobin, acute and chronic vascular diabetic complications. Conclusion: The present investigation revealed a high prevalence of non-severe mental disorders with predominance of generalized anxiety disorders and unipolar protracted depressions in T2DM in-patients and specific phobias in T1DM patients. Organic brain involvement (encephalopathy) occurs in every third young T1DM patient; however, in the majority of cases, its potential etiology is linked with factors unrelated to DM or non-specific for DM (for example, hypoglycemia). In routine medical practice, diagnostics and treatment of mental disorders in DM patients are close to non-existent.
About the authors
E. G. Starostina
Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
Author for correspondence.
Email: elena.starostina59@yandex.ru
MD, PhD, Professor, Chair of Endocrinology, Faculty of Postgraduate Medical Training, MONIKI Россия
E. N. Moshnyaga
Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
Email: fake@neicon.ru
MD, endocrinologist, Department for Consultation and Diagnostics, MONIKI Россия
M. N. Volodina
Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
Email: fake@neicon.ru
research fellow, Department of Therapeutic Endocrinology, MONIKI
РоссияT. S. Malakhova
Regional Hospital No.3; 1 Frunze ul., Shchelkovo, Shchelkovskiy r-n, Moscow Region, 141100, Russian Federation
Email: fake@neicon.ru
endocrinologist, Shchelkovo Regional Hospital No.1.
РоссияReferences
- Старостина ЕГ. Методические рекомендации для врачей первичного звена здравоохранения по ведению больных с эндокринными заболеваниями. В: Краснова ВН, ред. Сборник инструктивно-методических материалов для врачей первичного звена здравоохранения по оказанию помощи пациентам с непсихотическими психическими расстройствами (на основе полипрофессионального взаимодействия различных специалистов). Часть 2. М.: Медпрактика-М; 2012. с. 143-72. (Starostina EG. [Methodical recommendations for the first link physicians of the public health care for management of patients with endocrine diseases]. In: Krasnova VN, editor. [Collected instruction-and-methodology materials for the first link physicians of the public health care to render medical aid to the patients with non-psychotic mental disorders (based on the multidisciplinary interrelationship of different specialists)]. Pt 2. Moscow: Medpraktika-M; 2012. p. 143-72. Russian).
- Коркина МВ, Елфимова ЕВ, Марилов ВВ. Пограничные психические нарушения при сахарном диабете. Журнал невропатологии и психиатрии им. С.С. Корсакова. 1997;97(2):15-8. (Korkina MV, Elfimova EV, Marilov VV. [Border-line mental disorders in diabetes mellitus]. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1997;97(2):15-8. Russian).
- Суркова ЕВ, Дробижев МЮ, Мельникова ОГ, Захарчук ТА, Дедов ИИ. Сахарный диабет и сопутствующие депрессии. Проблемы эндокринологии. 2003;(6):11-6. (Surkova EV, Drobizhev MYu, Mel’nikova OG, Zakharchuk TA, Dedov II. [Diabetes mellitus and concomitant depressions]. Problemy endokrinologii. 2003;(6):11-6. Russian).
- Маркин СП. Поражение нервной системы при сахарном диабете. Методическое пособие. М.; 2008. (Markin SP. [Neurologic system impairment in diabetes mellitus. Methodology manual]. Moscow; 2008. Russian).
- Прихожан ВМ. Поражение нервной системы при сахарном диабете. М.: Медицина; 1981. (Prikhozhan VM. [Neurologic system impairment in diabetes mellitus]. Moscow: Meditsina; 1981. Russian).
- Милевский ММ, ред. Классификация болезней в психиатрии и наркологии. Пособие для врачей. М.: Триада-Х; 2003. (Milevskiy MM, editor. [Classification of diseases in psychiatry and narcology. Handbook for physicians]. Moscow: Triada-X; 2003. Russian).
- Тиганов АС, ред. Психиатрия: руководство для врачей. В двух томах. М.: Медицина; 2012. (Tiganov AS, editor. [Psychiatrics: Manual for physicians]. In 2 vol. Moscow: Meditsina; 2012. Russian).
- Бобров АЕ, Старостина ЕГ, Мошняга ЕН. Бензодиазепиновая проблема: о чем свидетельствует опыт применения тофизопама (Грандаксина). Современная терапия в психиатрии и неврологии. 2012;(4):19-25. (Bobrov AE, Starostina EG, Moshnyaga EN. [Benzodiazepin problem: what is the experience of Tophyzopam (Grandaxin) application indicative of]. Sovremennaya terapiya v psikhiatrii i nevrologii. 2012;(4):19-25. Russian).
- Старостина ЕГ. Биомедицинские и психосоциальные аспекты сахарного диабета и ожирения: взаимодействие врача и пациента и пути его оптимизации. Автореф. дис. … д-ра мед. наук. М.; 2003. (Starostina EG. [Biomedical and psychosocial aspects of diabetes mellitus and obesity: physician-patient interrelationship and the ways of its optimization] [dissertation]. Moscow; 2003. Russian).
- Kovacs M, Ho V, Pollock MH. Criterion and predictive validity of the diagnosis of adjustment disorder: a prospective study of youths with new-onset insulin-dependent diabetes mellitus. Am J Psychiatry. 1995;152(4):523-8.
- Lustman PJ. Anxiety disorders in adults with diabetes mellitus. Psychiatr Clin North Am. 1988;11(2):419-32.
- Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997;59(1):24-31.